Parkinson’s Disease Genes VPS35 and EIF4G1 Interact Genetically and Converge on α-Synuclein
暂无分享,去创建一个
E. Masliah | J. Frydman | K. Shen | A. Gitler | H. Lashuel | B. Spencer | A. Adame | J. Chartron | J. Fields | N. Kramer | Ling-bo Li | Simona Eleuteri | K. Kosberg | K. Stafa | Nripesh Dhungel
[1] Chuong B. Do,et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease , 2014, Nature Genetics.
[2] M. Farrer,et al. EIF4G1 gene mutations are not a common cause of Parkinson's disease in the Japanese population. , 2014, Parkinsonism & related disorders.
[3] G. Petsko,et al. Pharmacological chaperones stabilize retromer to limit APP processing. , 2014, Nature chemical biology.
[4] M. Kumar,et al. Ribosomal Protein s15 Phosphorylation Mediates LRRK2 Neurodegeneration in Parkinson’s Disease , 2014, Cell.
[5] S. Bardien,et al. EIF4G1 R1205H and VPS35 D620N mutations are rare in Parkinson's disease from South Africa , 2014, Neurobiology of Aging.
[6] C. Burd,et al. Retromer: a master conductor of endosome sorting. , 2014, Cold Spring Harbor perspectives in biology.
[7] Mohamad Saad,et al. Genetic comorbidities in Parkinson's disease. , 2014, Human molecular genetics.
[8] T. Ideker,et al. Exome Sequencing Links Corticospinal Motor Neuron Disease to Common Neurodegenerative Disorders , 2014, Science.
[9] M. Frick,et al. Surfactant Secretion in LRRK2 Knock-Out Rats: Changes in Lamellar Body Morphology and Rate of Exocytosis , 2014, PloS one.
[10] C. Burd,et al. A mechanism for retromer endosomal coat complex assembly with cargo , 2013, Proceedings of the National Academy of Sciences.
[11] Nancy Y. Villa,et al. Human Eukaryotic Initiation Factor 4G (eIF4G) Protein Binds to eIF3c, -d, and -e to Promote mRNA Recruitment to the Ribosome* , 2013, The Journal of Biological Chemistry.
[12] U. Muthane,et al. VPS35 and EIF4G1 mutations are rare in Parkinson's disease among Indians , 2013, Neurobiology of Aging.
[13] Y. Teo,et al. Patterns of Linkage Disequilibrium of LRRK2 across Different Races: Implications for Genetic Association Studies , 2013, PloS one.
[14] Vladimir Makarov,et al. The Sac1 Domain of SYNJ1 Identified Mutated in a Family with Early‐Onset Progressive Parkinsonism with Generalized Seizures , 2013, Human mutation.
[15] S. Pappatà,et al. Mutation in the SYNJ1 Gene Associated with Autosomal Recessive, Early‐Onset Parkinsonism , 2013, Human mutation.
[16] M. Farrer,et al. Advances in the genetics of Parkinson disease , 2013, Nature Reviews Neurology.
[17] K. Lunetta,et al. Association of TREM2 variants with Alzheimer's disease in African-Americans: For the Alzheimer's Disease Genetics Consortium (ADGC) , 2013, Alzheimer's & Dementia.
[18] M. Pericak-Vance,et al. Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP) , 2013, Translational Psychiatry.
[19] K. Majamaa,et al. Mutations in EIF4G1 are not a common cause of Parkinson's disease , 2013, European journal of neurology.
[20] E. Masliah,et al. Axonopathy in an α-synuclein transgenic model of Lewy body disease is associated with extensive accumulation of C-terminal-truncated α-synuclein. , 2013, The American journal of pathology.
[21] K. Marder,et al. RAB7L1 Interacts with LRRK2 to Modify Intraneuronal Protein Sorting and Parkinson’s Disease Risk , 2013, Neuron.
[22] A. Amon,et al. Aneuploidy causes proteotoxic stress in yeast. , 2012, Genes & development.
[23] J. Trojanowski,et al. Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice , 2012, Science.
[24] P. S. St George-Hyslop,et al. Vps10 Family Proteins and the Retromer Complex in Aging-Related Neurodegeneration and Diabetes , 2012, The Journal of Neuroscience.
[25] A. Bonnet,et al. EIF4G1 in familial Parkinson's disease: pathogenic mutations or rare benign variants? , 2012, Neurobiology of Aging.
[26] C. Reitz. The role of intracellular trafficking and the VPS10d receptors in Alzheimer's disease. , 2012, Future neurology.
[27] J. Hardy,et al. Study of the genetic variability in a Parkinson's Disease gene: EIF4G1 , 2012, Neuroscience Letters.
[28] J. Massano,et al. Clinical approach to Parkinson's disease: features, diagnosis, and principles of management. , 2012, Cold Spring Harbor perspectives in medicine.
[29] Chuong B. Do,et al. Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database , 2012, PLoS genetics.
[30] P. Walter,et al. The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation , 2011, Science.
[31] Tapan P. Patel,et al. Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death , 2011, Neuron.
[32] Michael K. Hutchinson,et al. Translation initiator EIF4G1 mutations in familial Parkinson disease. , 2011, American journal of human genetics.
[33] M. Farrer,et al. VPS35 mutations in Parkinson disease. , 2011, American journal of human genetics.
[34] Ying Sun,et al. Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies , 2011, Cell.
[35] Nicholas Eriksson,et al. Web-Based Genome-Wide Association Study Identifies Two Novel Loci and a Substantial Genetic Component for Parkinson's Disease , 2011, PLoS genetics.
[36] Simon C. Potter,et al. A Two-Stage Meta-Analysis Identifies Several New Loci for Parkinson's Disease , 2011, PLoS genetics.
[37] Mohamad Saad,et al. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies , 2011, The Lancet.
[38] Sarah E. Walker,et al. Multiple elements in the eIF4G1 N‐terminus promote assembly of eIF4G1•PABP mRNPs in vivo , 2011, The EMBO journal.
[39] H. Feldman,et al. Sortilin-Mediated Endocytosis Determines Levels of the Frontotemporal Dementia Protein, Progranulin , 2010, Neuron.
[40] T. Golde,et al. Sorting Out Frontotemporal Dementia? , 2010, Neuron.
[41] J. Nutt,et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson’s disease , 2010, Nature Genetics.
[42] Emily K. Lehrman,et al. Two Cyclin-Dependent Kinase Pathways Are Essential for Polarized Trafficking of Presynaptic Components , 2010, Cell.
[43] A. Gitler,et al. GTPase Activity Plays a Key Role in the Pathobiology of LRRK2 , 2010, PLoS genetics.
[44] J. Doudna,et al. Functional Overlap between eIF4G Isoforms in Saccharomyces cerevisiae , 2010, PloS one.
[45] Yusuke Nakamura,et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease , 2009, Nature Genetics.
[46] E. Masliah,et al. Beclin 1 Gene Transfer Activates Autophagy and Ameliorates the Neurodegenerative Pathology in α-Synuclein Models of Parkinson's and Lewy Body Diseases , 2009, The Journal of Neuroscience.
[47] Sonja W. Scholz,et al. Genome-Wide Association Study reveals genetic risk underlying Parkinson’s disease , 2009, Nature Genetics.
[48] E. Mufson,et al. Brainstem Alzheimer's-like pathology in the triple transgenic mouse model of Alzheimer's disease , 2009, Neurobiology of Disease.
[49] M. Zeviani,et al. Faculty Opinions recommendation of Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. , 2009 .
[50] D. Karger,et al. Bridging high-throughput genetic and transcriptional data reveals cellular responses to alpha-synuclein toxicity , 2009, Nature Genetics.
[51] U. Baumann,et al. Crystal structure of the yeast eIF4A-eIF4G complex: An RNA-helicase controlled by protein–protein interactions , 2008, Proceedings of the National Academy of Sciences.
[52] E. Masliah,et al. Statins reduce neuronal α‐synuclein aggregation in in vitro models of Parkinson’s disease , 2008, Journal of neurochemistry.
[53] J. Jankovic. Parkinson’s disease: clinical features and diagnosis , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[54] A. Gitler. Beer and Bread to Brains and Beyond: Can Yeast Cells Teach Us about Neurodegenerative Disease? , 2007, Neurosignals.
[55] J. Shorter. Hsp104: A Weapon to Combat Diverse Neurodegenerative Disorders , 2007, Neurosignals.
[56] K. Shen,et al. Wnt Signaling Positions Neuromuscular Connectivity by Inhibiting Synapse Formation in C. elegans , 2007, Cell.
[57] J. Hay. Faculty Opinions recommendation of Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. , 2007 .
[58] J. Trojanowski,et al. Mechanisms of Parkinson's Disease Linked to Pathological α-Synuclein: New Targets for Drug Discovery , 2006, Neuron.
[59] S. Lindquist,et al. α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models , 2006, Science.
[60] Sean R. Collins,et al. A strategy for extracting and analyzing large-scale quantitative epistatic interaction data , 2006, Genome Biology.
[61] Sunhong Kim,et al. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin , 2006, Nature.
[62] Changan Jiang,et al. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin , 2006, Nature.
[63] Andrew B West,et al. Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[64] David Botstein,et al. GO: : TermFinder--open source software for accessing Gene Ontology information and finding significantly enriched Gene Ontology terms associated with a list of genes , 2004, Bioinform..
[65] John Q Trojanowski,et al. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs , 2004, Nature Medicine.
[66] S. Lindquist,et al. Yeast Cells Provide Insight into Alpha-Synuclein Biology and Pathobiology , 2003, Science.
[67] Janel O. Johnson,et al. α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.
[68] Patrizia Rizzu,et al. Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism , 2002, Science.
[69] Makoto Hashimoto,et al. Differential neuropathological alterations in transgenic mice expressing α‐synuclein from the platelet‐derived growth factor and Thy‐1 promoters , 2002, Journal of neuroscience research.
[70] P. Madsen,et al. The Yeast Vps10p Cytoplasmic Tail Mediates Lysosomal Sorting in Mammalian Cells and Interacts with Human GGAs* , 2002, The Journal of Biological Chemistry.
[71] P. Walter,et al. Intracellular signaling from the endoplasmic reticulum to the nucleus: the unfolded protein response in yeast and mammals. , 2001, Current opinion in cell biology.
[72] P. Steiner,et al. Syntaxin 13 is a developmentally regulated SNARE involved in neurite outgrowth and endosomal trafficking , 2000, The European journal of neuroscience.
[73] L. Mucke,et al. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. , 2000, Science.
[74] S. Lovestone,et al. UK Alzheimer's Disease Genetics Consortium , 1999, International journal of geriatric psychiatry.
[75] Scott D. Emr,et al. A Membrane Coat Complex Essential for Endosome-to-Golgi Retrograde Transport in Yeast , 1998, The Journal of cell biology.
[76] H. Payami,et al. Genetic Epidemiology of Parkinson's Disease , 1998, Journal of geriatric psychiatry and neurology.
[77] S. Emr,et al. Endosome to Golgi Retrieval of the Vacuolar Protein Sorting Receptor, Vps10p, Requires the Function of the VPS29, VPS30, and VPS35 Gene Products , 1997, The Journal of cell biology.
[78] V. Bonifati. Genetics of Parkinson's disease--state of the art, 2013. , 2014, Parkinsonism & related disorders.
[79] A. Samii,et al. Association mapping of the PARK10 region for Parkinson's disease susceptibility genes. , 2014, Parkinsonism & related disorders.
[80] A. Tong,et al. Synthetic genetic array analysis in Saccharomyces cerevisiae. , 2006, Methods in molecular biology.
[81] A. Singleton,et al. alpha-Synuclein locus triplication causes Parkinson's disease. , 2003, Science.